Company / Revenue per Share
Insulet Corporation Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$38.58
FY2025
5-year range
$11.18 / $38.58
FY2021-FY2025
Trend
+30.2%
vs FY2024
Sector context
#51 of 153
Health Care
What the data says
At $38.58, Insulet Corporation's revenue per share ranks #51 of 153 in the Health Care sector. Revenue per Share has increased for 6 consecutive years, from $7.84 in FY2019 to $38.58 in FY2025.
Based on SEC 10-K filings.
38.58 in FY2025 with a 5-year CAGR of +33.8%.
Improved from $24.41 to $38.58 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +43.4%
- 5-Year CAGR
- +33.8%
- 10-Year CAGR
- -
Sector benchmark
#51 of 153 in Health CareTop 33% of 153This company $38.58 Sector average $124.28
▼
-69.0% below sector average
Key checks
Key Insights
- Insulet Corporation's revenue per share has grown for 6 consecutive years.
- In FY2025, revenue per share increased 30.2% year-over-year.
- Ranks #51 out of 153 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.58 | +30.2% |
| FY2024 | $29.63 | +21.4% |
| FY2023 | $24.41 | +86.8% |
| FY2022 | $13.07 | +16.9% |
| FY2021 | $11.18 | +24.3% |
| FY2020 | $8.99 | +14.8% |
| FY2019 | $7.84 | -18.9% |
| FY2018 | $9.67 | +19.8% |
| FY2017 | $8.07 | +25.3% |
| FY2016 | $6.44 | +37.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026